Avalyn Pharma
The Associate Director, Nonclinical Development will serve as a key scientific contributor within Avalyn's Translational Sciences organization, supporting the advancement of the pipeline through pre‑clinical and clinical stages. The role focuses on applying pharmacology expertise to design and oversee nonclinical studies, integrate translational data into IND packages, and communicate findings to cross‑functional teams and regulatory agencies.
Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company's approach focuses on delivering inhaled formulations of established medicines directly to lung tissue to potentially enhance efficacy and reduce systemic side effects. Its pipeline includes two clinical-stage programs, AP01 (inhaled pirfenidone) and AP02 (inhaled nintedanib), as well as a preclinical program, AP03, a fixed-dose combination of both agents.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Avalyn Pharma.
19% below the average for this role
Avalyn Pharma
Aug 5, 2025
Translational Lead
Tonix Pharmaceuticals
Senior Scientist
Amgen
Director of Nonclinical Development, Toxicology
Rhythm Pharmaceuticals
Nonclinical Safety Lead
BioLife Plasma Services
Director, Toxicology Translational Science
Tarsus Pharmaceuticals
Vice President, Translational Medicine & Clinical Pharmacology
Rigel Pharmaceuticals